A large set of novel shared minor histocompatibility antigens (mHAs) driving graft-versus-leukemia (GVL) responses was discovered and experimentally validated using Complete Omics’ Valid-NEO ultra-sensitive immunopeptidomics
Dr. Hui Zhang is a professor at Johns Hopkins University, where she directs mass spectrometry and biomarker discovery programs. Her work includes PTM antibodies, immunoaffinity mass spectrometry, and glycoproteomic technologies.
Liang Zhao, PhD, is an analytical chemist specializing in immuno-metabolism and anti-tumor drug discovery. At Johns Hopkins University, he co-founded the first metabolomics core facility at the Bloomberg School of Public Health.
Dr. Naseruddin Höti is a clinical laboratory expert in clinical chemistry, toxicology, virology, and assay development. Dr. Naseruddin Höti completed a ComACC-accredited Clinical Chemistry Fellowship at the University of Maryland Medical Center.